Nanopore Sequencing Market will Reflect Significant Growth Prospects during 2021 – 2026

1
Nanopore Sequencing Market Analysis By Top Key
Players Oxford Nanopore Technologies (UK),
Stratos Genomics, a Roche company (US)
2
Nanopore Sequencing, a fourth-generation
sequencing technology, in which single strands of
DNA or RNA are passed through tiny protein
channel called as nanopore. These nanopores are
embedded in an electrically resistant membrane
that causes changes in the ion current,
determining the sequence and modifications of
bases. The Global Nanopore Sequencing Market
valued at 200 million (2021) is set to witness a
significant growth rate of 26 in the next 5
years. Some of the main factors propelling the
Global Nanopore Sequencing Market is the
advantages of nanopore sequencing such as high
throughput ultra-long reads, technological
developments in nanopore technologies, growing
prevalence of infectious diseases, and rising
investments in RD. Advantages of nanopore
sequencing technology fuels the Nanopore
Sequencing Market Demand Over the years, there
has been a substantial growth in the acceptance
of nanopore sequencing for research as well as
clinical applications because of significant
advantages of nanopores such as label-free
ultralong reads and high throughput.
3

• Some of the main advantages boosting its demand
  are
• Long-read sequencing The ability to produce
  ultra-long reads of over 2 Mb is a major
  advantage of nanopore sequencing. Longer read
  lengths are more likely to cover full regions of
  repeated sequence and structural variation,
  allowing for a more comprehensive understanding
  of genetic variants and the reconstruction of
  complex genomes
• Targeted sequencing For nanopore sequencing, a
  variety of targeted sequencing approaches, such
  as targeted panels and whole exome enrichment,
  are available, leveraging both PCR- and hybrid
  capture-based targeted enrichment strategies
• Rapid results Unlike traditional sequencing
  approaches, which need analysis after sequencing
  is completed, nanopore sequencing allows for
  early insights to be gained as soon as the
  sequencing process begins
• Low cost of sequencer High-end sequencers from
  Illumina and PacBio are priced over 950k and
  450k respectively which are too expensive as
  compared to the GridION nanopore-based sequencer
  offered by Oxford Nanopore Technologies at 49k
• Increasing clinical applications Nanopore
  sequencing is widely used for pathogen analysis
  such as outbreak surveillance of infectious
  diseases such as tuberculosis, Ebola, Zika,
  dengue fever, and Covid19, among others. Nanopore
  sequencing is also widely used by researchers and
  clinicians for cancer genomics and genetic
  disease diagnosis.
• Explore Premium Report on Nanopore Sequencing
  Market _at_ https//meditechinsights.com/nanopore-seq
  uencing-market/

4

• Partnerships and acquisition to increase adoption
  and co-develop advanced solutions
• The nanopore sequencing market has witnessed a
  number of partnerships and acquisition by market
  players to either improve the acceptance of this
  technology for clinical applications or to
  co-develop advanced sequencing platforms.
• The following is a list of some of the strategic
  initiatives that boost the adoption of nanopore
  sequencing
• In April 2022, Oxford Nanopore Technologies collab
  orated with Genomics England to evaluate the
  benefits of sequencing for enhancing patient care
  and advancing research activities for the
  development of novel treatments on a larger scale
  using nanopore sequencing technology
• In September 2021, Oxford Nanopore
  Technologies collaborated with Oracle to explore
  novel applications of genomic sequencing using
  the Oracle Cloud Infrastructure (OCI) to speed-up
  discovery of medical innovations
• In August 2020, Oxford Nanopore
  Technologies entered into an agreement with the
  UKs Department of Health and Social Care, to
  roll out its LamPORE SARS-CoV-2 tests at a number
  of NHS testing laboratories
• In May 2020, F. Hoffmann-La Roche Ltd acquired
  Stratos Genomics, a US based fourth-generation
  genetic sequencing company, to advance the
  development of nanopore sequencer for diagnostic
  applications with the combination of electronics
  and biological components

5
Competitive Landscape Analysis of Nanopore
Sequencing Market The global nanopore sequencing
market is marked by the presence of key players
such as Oxford Nanopore Technologies (UK),
Stratos Genomics, a Roche company (US), BaseClear
B.V. (Netherlands), CD Genomics (US), and
others. For More Detailed Insights, Contact Us
_at_ https//meditechinsights.com/contact-us/ About
Medi-Tech Insights Medi-Tech Insights is a
healthcare-focused business research insights
firm. Our clients include Fortune 500 companies,
blue-chip investors hyper-growth start-ups. We
have completed 100 projects in Digital Health,
Healthcare IT, Medical Technology, Medical
Devices Pharma Services. Contact Ruta
Halde Associate, Medi-Tech Insights 32 498 86 80
79 info_at_meditechinsights.com